Evidence map›Paper›PMID 41168643›Full record

ArticleContact dermatitis2026

Severe Delayed Hypersensitivity Reaction at Guselkumab Injection Site.

Salomé Allichon, Julie Litovsky, Michèle Sanchez, Céline Girard, Guillaume Granier, Luc Durand, Maxime Henrion, Christelle Philibert, Cosette Le Souder, Nadia Raison-Peyron

Abstract readCase Reports
In one paragraph

Article in Contact dermatitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Salomé AllichonDepartment of Dermatology, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0009-0009-1441-6254
Julie LitovskyDepartment of Dermatology, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0009-0007-3780-6816
Michèle SanchezDepartment of Dermatology, Hospital of Avignon, Avignon, France.ORCID https://orcid.org/0000-0003-4760-4058
Céline GirardDepartment of Dermatology, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0000-0002-9666-6354
Guillaume GranierDepartment of Pathology, Hospital of Avignon, Avignon, France.
Luc DurandDepartment of Pathology, Montpellier University Hospital, Montpellier, France.
Maxime HenrionDepartment of Pathology, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0000-0002-3643-2812
Christelle PhilibertDepartment of Pharmacovigilance, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0009-0003-8377-0720
Cosette Le SouderDepartment of Pharmacovigilance, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0000-0002-5107-3862
Nadia Raison-PeyronDepartment of Dermatology, Montpellier University Hospital, Montpellier, France.ORCID https://orcid.org/0000-0002-7991-3165

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse reactionanti‐IL23biologic agentscase reportdelayed hypersensitivityguselkumabinjection site reactionpsoriasis

Identifiers

PMID41168643
PMCPMC12695513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.